Replenishing the NAD+ pool via the salvage pathway
NAD+ Pool Repletion · Cellular bioenergetics and mitochondrial dynamics
Generates nicotinamide adenine dinucleotide (NAD+) through NMNAT and NRK enzyme reactions. It supplies electron acceptors for the tricarboxylic acid (TCA) cycle and replaces the NAD+ used up by SIRT and PARP enzymes.
Supplements acting on this mechanism (ranked by strength and evidence)
NMN (nicotinamide mononucleotide)
NMN is converted directly to NAD+ by NMNAT1-3 and is a key precursor for NAD+ synthesis. Human randomized trials showed that blood NAD+ rises after oral dosing, but responses differ across tissues and cell compartments, and results in skeletal muscle are inconsistent.
Nicotinamide riboside (NR)
NR is phosphorylated by NRK1/NRK2 to form NMN, which is then converted to NAD+. In a human randomized trial, 100, 300 and 1000 mg/day raised whole-blood NAD+ by an average of about 22%, 51% and 142%, respectively. This result comes from blood, and the size of the increase differs between tissues.
Immediate-release niacin (vitamin B3)
Niacin is converted via the Preiss–Handler pathway, catalyzed by NAPRT, into nicotinic acid mononucleotide, which is then used to synthesize NAD+. This is a known synthesis route in humans. Human studies have confirmed that niacin is a precursor of NAD+, but the size of the rise depends on dose, tissue and nutritional status.